4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Niagen Bioscience, Inc. (NAGE) operates in the Biotechnology industry and is headquartered in Los Angeles, United States with about 117 employees. Its market capitalization is roughly $276 million. In the fiscal year ended 2025-12-31, NAGE reported $129M in revenue and $17M in net income.
Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments.
Interactive charts & full statements → Open the NAGE valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $129M | $100M | $84M | $72M | — |
| Gross Profit | $83M | $62M | $51M | $43M | — |
| Operating Income (EBIT) | $14M | $8M | ($6M) | ($19M) | — |
| Net Income | $17M | $9M | ($5M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $32M | $34M | $34M | $31M | $30M |
| Gross Profit | $20M | $22M | $22M | $20M | $19M |
| Operating Income (EBIT) | $2M | $2M | $4M | $3M | $5M |
| Net Income | $6M | $4M | $5M | $4M | $5M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $106M | $68M | $55M | $54M | — |
| Total Liabilities | $30M | $22M | $26M | $25M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive NAGE viewer.
About TickerBase · Data methodology & sources